• About Us
    • Overview
    • Management Team
      • Charles H Large
      • Giuseppe S. Alvaro
      • Daniel Umbricht
      • Barbara Domayne-Hayman
      • Martin Pue
      • Martin Gunthorpe
      • Hannah Selin
      • Wendy Kennedy
    • Board of Directors
    • Investors
  • Pipeline
    • Overview
    • Fragile X Syndrome
    • Orphan Epilepsy Syndromes
  • Science
  • Partnering
  • News & Events
    • Publications
  • Contact Us
  • Menu Menu

AUT00206, a Kv3 channel modulator with potential for the treatment of Fragile X Syndrome

28 June 2022
Read more
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg 0 0 Editor https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg Editor2022-06-28 17:32:362022-08-17 15:25:21AUT00206, a Kv3 channel modulator with potential for the treatment of Fragile X Syndrome
  • About Us
    • Overview
    • Management Team
      • Charles H Large
      • Giuseppe S. Alvaro
      • Daniel Umbricht
      • Barbara Domayne-Hayman
      • Martin Pue
      • Martin Gunthorpe
      • Hannah Selin
      • Wendy Kennedy
    • Board of Directors
    • Investors
  • Pipeline
    • Overview
    • Fragile X Syndrome
    • Orphan Epilepsy Syndromes
  • Science
  • Partnering
  • News & Events
    • Publications
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • LinkedIn
© Autifony Therapeutics
Website by FisherPaul
  • Privacy Policy
  • Terms & Conditions
Scroll to top